Clinical Trials Directory

Trials / Unknown

UnknownNCT02375152

Safety and Effectiveness of Capsulotomy in Refractory OCD

Safety and Effectiveness of Capsulotomy in Refractory Obsessive-Compulsive Disorder

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Obsessive-compulsive disorder (OCD) is a severely disabling psychiatric disorder with a worldwide lifetime prevalence of 2-3% (Islam et al., 2015).Despite the efficacy of pharmacological and behavioural treatment methods for most OCD patients, roughly one third do not demonstrate significant symptom improvement, even after aggressive treatment (Foa et al, 2007). The effectiveness of neurosurgical treatment methods (including ablative surgery) for those with severely disabling treatment resistant OCD is substantiated by clinical research (Greenberg, Rauch \& Haber, 2010). The brain target of this procedure is usually the area between the anterior and middle third of the anterior limb of the internal capsule.

Conditions

Interventions

TypeNameDescription
PROCEDUREAnterior Capsulotomy

Timeline

Start date
2015-04-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2015-03-02
Last updated
2015-04-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02375152. Inclusion in this directory is not an endorsement.